list of fda approved glp-1 receptor agonists Overview Available in the United States for How GLP-1 medications are transforming

Both tirzepatide and semaglutide come with boxed warnings from the FDA (the strongest safety warning for prescription drugs) about the risk of developing thyroid C-cell tumors

B12 injections, hormone support, and nutrition plans are often used safely during breastfeeding

Microdosing may lead to unpredictable side effects and interactions with other medications

However, while the hypertensive effect of GLP-1 is not abolished by inhibition of -adrenergic signaling [634], exendin-4 induction of HR is blocked by the -adrenergic receptor antagonist propranolol [639], and exendin-4 fails to affect HR in adrenalectomized rats (as reviewed in [622])

Ozempic, a GLP-1 receptor agonist used for diabetes management and weight loss, can exacerbate or contribute to the development of gastroparesis due to its effects on slowing gastric emptying

2016, doi: 10.1038/srep23074